Order Article Reprints

Santos E, Clark C, Biag HMB, Tang SJ, Kim K, Ponzini MD, Schneider A, Giulivi C, Montanaro FAM, Gipe JT-E, et al. Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS). Cells. 2023; 12(24):2773. https://doi.org/10.3390/cells12242773

Santos, Ellery, Courtney Clark, Hazel Maridith B. Biag, Si Jie Tang, Kyoungmi Kim, Matthew D. Ponzini, Andrea Schneider, Cecilia Giulivi, Federica Alice Maria Montanaro, Jesse Tran-Emilia Gipe, and et al. 2023. "Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS)" Cells 12, no. 24: 2773. https://doi.org/10.3390/cells12242773

Santos, E., Clark, C., Biag, H. M. B., Tang, S. J., Kim, K., Ponzini, M. D., Schneider, A., Giulivi, C., Montanaro, F. A. M., Gipe, J. T.-E., Dayton, J., Randol, J. L., Yao, P. J., Manolopoulos, A., Kapogiannis, D., Hwang, Y. H., Hagerman, P., Hagerman, R., & Tassone, F. (2023). Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS). Cells, 12(24), 2773. https://doi.org/10.3390/cells12242773